Alkermes (ALKS) Receivables (2011 - 2026)
Alkermes (ALKS) reported Receivables of $407.6 million for Q1 2026, up 26.69% year-over-year from $321.8 million in Q1 2025, and up 22.04% quarter-over-quarter from $334.0 million in Q4 2025.
Alkermes (ALKS) Receivables (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Receivables data on file, last reported at $407.6 million in Q1 2026.
- Receivables for Q1 2026 came in at $407.6 million, up 26.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $407.6 million (up 26.69% YoY), and the FY2025 annual result was $334.0 million, down 14.25% from the prior year.
- Receivables climbed to $407.6 million in Q1 2026 per ALKS's latest filing, from $334.0 million in the prior quarter.
- Over five years, Receivables peaked at $407.6 million in Q1 2026 and troughed at $250.0 million in Q1 2022.
- A 5-year average of $328.5 million and a median of $334.0 million in 2025 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables retreated 15.69% in 2022, then increased 27.5% in 2023.
- A 5-year view of Receivables shows it stood at $296.9 million in 2022, then increased by 12.22% to $333.2 million in 2023, then grew by 16.91% to $389.5 million in 2024, then retreated by 14.25% to $334.0 million in 2025, then gained by 22.04% to $407.6 million in 2026.
- Business Quant data shows ALKS's Receivables at $407.6 million in Q1 2026, $334.0 million in Q4 2025, and $355.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 355.67 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 149.62 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 74.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407.63 Mn |
| Dec 31, 2025 | 334.03 Mn |
| Sep 30, 2025 | 355.11 Mn |
| Jun 30, 2025 | 356.33 Mn |
| Mar 31, 2025 | 321.75 Mn |
| Dec 31, 2024 | 389.52 Mn |
| Sep 30, 2024 | 370.18 Mn |
| Jun 30, 2024 | 369.91 Mn |
| Mar 31, 2024 | 317.08 Mn |
| Dec 31, 2023 | 333.18 Mn |
| Sep 30, 2023 | 340.46 Mn |
| Jun 30, 2023 | 334.48 Mn |
| Mar 31, 2023 | 277.61 Mn |
| Dec 31, 2022 | 296.90 Mn |
| Sep 30, 2022 | 267.28 Mn |
| Jun 30, 2022 | 262.33 Mn |
| Mar 31, 2022 | 250.04 Mn |
| Dec 31, 2021 | 326.56 Mn |
| Sep 30, 2021 | 297.67 Mn |
| Jun 30, 2021 | 311.15 Mn |